-
-
-
-
-
-
-
KemPharm, Inc. Expands Pain Therapy Pipeline With Discovery of KP746
-
-
-
-
-
-
-
KemPharm, Inc. Completes Human Abuse Liability Program for KP201/APAP
-
-
-
-
-
-
-
KemPharm to Highlight the Potential of Prodrugs at the 9th Annual Pain & Migraine Therapeutics Summit
-
-
-
-
-
-
-
KemPharm, Inc. to Report Q2 2015 Results
-
-
-
-
-
-
-
KemPharm, Inc. Reports Positive Data From Oral Human Abuse Liability Clinical Trial of KP201/APAP
-
-
-
64,524 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

